MFRHX
Price
$60.68
Change
+$0.55 (+0.91%)
Updated
Jul 3 closing price
Net Assets
8.12B
VSMPX
Price
$281.45
Change
+$2.40 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

MFRHX vs VSMPX

Header iconMFRHX vs VSMPX Comparison
Open Charts MFRHX vs VSMPXBanner chart's image
MFS Research R3
Price$60.68
Change+$0.55 (+0.91%)
VolumeN/A
Net Assets8.12B
Vanguard Total Stock Mkt Idx Instl Pls
Price$281.45
Change+$2.40 (+0.86%)
VolumeN/A
Net Assets1.82T
MFRHX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFRHX vs. VSMPX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRHX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. MFRHX (8.12B). VSMPX pays higher dividends than MFRHX: VSMPX (1.22) vs MFRHX (0.43). MFRHX was incepted earlier than VSMPX: MFRHX (20 years) vs VSMPX (10 years). MFRHX (0.77) is less costly to investors than VSMPX (0.02). MFRHX is a more actively managed with annual turnover of: 20.00 vs. VSMPX (2.00). MFRHX has a lower initial minimum investment than VSMPX: MFRHX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 13.90 vs. MFRHX (2.24). VSMPX return over 5 years is better than : 95.69 vs. MFRHX (35.86).
MFRHXVSMPXMFRHX / VSMPX
Total Expense Ratio0.770.023,850%
Annual Report Gross Expense Ratio0.770.023,850%
Fund Existence20 years10 years-
Gain YTD6.3076.42698%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.12B1.82T0%
Annual Yield % from dividends0.431.2235%
Returns for 1 year2.2413.9016%
Returns for 3 years26.5062.1743%
Returns for 5 years35.8695.6937%
Returns for 10 years66.02189.2135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
WHD45.270.01
+0.02%
Cactus
STT109.49N/A
N/A
State Street Corp